vanadates has been researched along with Prostatic Neoplasms in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (33.33) | 18.2507 |
| 2000's | 5 (33.33) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chmur, K; Chmurzyński, L; Grabowska, O; Kapica, M; Milaș, D; Tesmar, A; Wyrzykowski, D; Żamojć, K; Zdrowowicz, M | 1 |
| Alho, I; Castiglioni, J; Correia, I; Costa Pessoa, J; Gambino, D; Marques, F; Mosquillo, MF; Pérez, L; Rostán, S; Scalese, G | 1 |
| Chen, SM; Karthik, R; Kokulnathan, T; Kumar, JV; Sakthinathan, S | 1 |
| Ahn, KS; Baek, SH; Kim, C; Ko, JH; Lee, JH; Lee, SG; Sethi, G; Um, JY; Yang, WM | 1 |
| Liu, TT; Liu, YJ; Wang, K; Wang, Q; Yang, XG | 1 |
| Ha, J; Hwang, JT; Jung, SN; Kang, I; Kim, SS; Lee, HJ; Lee, M | 1 |
| Golovko, O; Lou, YR; Nazarova, N; Qiao, S; Tuohimaa, P | 1 |
| Ha, J; Hwang, JT; Kim, EJ; Kim, MJ; Kim, SS; Lee, M; Yun, H | 1 |
| Fritz, WA; Lin, TM; Peterson, RE | 1 |
| Atfi, A; Boissonneault, M; Chapdelaine, A; Chevalier, S; Drobetsky, E | 1 |
| Bianchi, R; Brevini, TA; Motta, M | 1 |
| Hrzenjak, M; Shain, SA | 1 |
| Cohen, MB; Rokhlin, OW | 1 |
| Hsu, CP; Mai, XY; Sheu, JC; Yang, CC; Yang, SD | 1 |
| Ding, M; Gao, N; Jiang, BH; Leonard, SS; Liu, KJ; Shi, X; Zhang, Z; Zheng, JZ | 1 |
15 other study(ies) available for vanadates and Prostatic Neoplasms
| Article | Year |
|---|---|
Implications of albumin in cell culture media on the biological action of vanadates(V).
Topics: Cell Culture Techniques; Humans; Male; Prostatic Neoplasms; Serum Albumin, Bovine; Vanadates; Vanadium | 2023 |
Heteroleptic oxidovanadium(IV) complexes of 2-hydroxynaphtylaldimine and polypyridyl ligands against Trypanosoma cruzi and prostate cancer cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Chagas Disease; Coordination Complexes; Humans; Male; Prostatic Neoplasms; Pyridines; Trypanocidal Agents; Trypanosoma cruzi; Vanadates | 2017 |
A cerium vanadate interconnected with a carbon nanofiber heterostructure for electrochemical determination of the prostate cancer drug nilutamide.
Topics: Antineoplastic Agents; Carbon; Cerium; Electrochemical Techniques; Electrodes; Humans; Hydrogen-Ion Concentration; Imidazolidines; Limit of Detection; Male; Nanofibers; Prostatic Neoplasms; Reproducibility of Results; Vanadates | 2019 |
Capsazepine inhibits JAK/STAT3 signaling, tumor growth, and cell survival in prostate cancer.
Topics: A549 Cells; Animals; Antineoplastic Agents; Apoptosis; Capsaicin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Enzyme Activation; Humans; Janus Kinase 1; Ki-67 Antigen; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Phosphorylation; Prostatic Neoplasms; Protein Tyrosine Phosphatases; Receptor-Like Protein Tyrosine Phosphatases, Class 4; RNA Interference; RNA, Small Interfering; STAT3 Transcription Factor; Vanadates; Xenograft Model Antitumor Assays | 2017 |
Reactive-oxygen-species-mediated Cdc25C degradation results in differential antiproliferative activities of vanadate, tungstate, and molybdate in the PC-3 human prostate cancer cell line.
Topics: Antineoplastic Agents; cdc25 Phosphatases; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Humans; Male; Molybdenum; Prostatic Neoplasms; Reactive Oxygen Species; Tungsten Compounds; Vanadates | 2012 |
AMP-activated protein kinase activity is required for vanadate-induced hypoxia-inducible factor 1alpha expression in DU145 cells.
Topics: Adenosine Triphosphate; AMP-Activated Protein Kinases; Cell Hypoxia; Enzyme Activation; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Multienzyme Complexes; Phosphatidylinositol 3-Kinases; Prostatic Neoplasms; Protein Kinases; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; RNA, Messenger; RNA, Neoplasm; Signal Transduction; TOR Serine-Threonine Kinases; Transcription Factors; Tumor Cells, Cultured; Vanadates | 2004 |
Calcitriol-induced prostate-derived factor: autocrine control of prostate cancer cell growth.
Topics: Antineoplastic Agents; Benzothiazoles; Bone Morphogenetic Proteins; Calcitriol; Calcium Channel Agonists; Cell Line, Tumor; Cell Proliferation; Dactinomycin; Dihydrotestosterone; DNA, Complementary; DNA, Neoplasm; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Growth Differentiation Factor 15; Humans; Male; Membrane Proteins; Prostatic Neoplasms; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Thiazoles; Toluene; Vanadates | 2004 |
Critical roles of AMP-activated protein kinase in the carcinogenic metal-induced expression of VEGF and HIF-1 proteins in DU145 prostate carcinoma.
Topics: Adenoviridae; AMP-Activated Protein Kinases; Arsenates; Carcinogens; Cell Line, Tumor; Cell Survival; Cobalt; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation, Neoplastic; Gene Transfer Techniques; Humans; Hypoxia-Inducible Factor 1; Male; Metals; Multienzyme Complexes; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Vanadates; Vascular Endothelial Growth Factor A | 2006 |
The aryl hydrocarbon receptor (AhR) inhibits vanadate-induced vascular endothelial growth factor (VEGF) production in TRAMP prostates.
Topics: Animals; Aryl Hydrocarbon Receptor Nuclear Translocator; Dimerization; Humans; Male; Mice; Mice, Knockout; Mice, Transgenic; Neovascularization, Pathologic; Prostatic Neoplasms; Receptors, Aryl Hydrocarbon; Transplantation, Heterologous; Vanadates; Vascular Endothelial Growth Factor A | 2008 |
Transforming growth factor beta down-regulates Src family protein tyrosine kinase signaling pathways.
Topics: Blotting, Western; Cell Line; Humans; Male; Oncogene Protein pp60(v-src); Oncogene Proteins, Viral; Phosphoproteins; Phosphotyrosine; Prostatic Neoplasms; Protein-Tyrosine Kinases; Receptors, Transforming Growth Factor beta; Signal Transduction; src-Family Kinases; Transforming Growth Factor beta; Tumor Cells, Cultured; Tyrosine; Vanadates | 1994 |
Direct inhibitory effect of somatostatin on the growth of the human prostatic cancer cell line LNCaP: possible mechanism of action.
Topics: Cell Division; Deoxyadenine Nucleotides; DNA; Electrophoresis, Polyacrylamide Gel; Humans; Male; Methionine; Prostatic Neoplasms; Protein Biosynthesis; Proteins; RNA; Somatostatin; Tumor Cells, Cultured; Uridine; Vanadates | 1993 |
Protein kinase C-dependent and -independent pathways of signal transduction in prostate cancer cells: fibroblast growth factor utilization of a protein kinase C-independent pathway.
Topics: Animals; Cell Division; Down-Regulation; Fibroblast Growth Factor 1; Fibroblast Growth Factors; Male; Neoplasm Proteins; Phosphorylation; Prostatic Neoplasms; Protein Kinase C; Rats; Signal Transduction; Tetradecanoylphorbol Acetate; Thymidine; Tumor Cells, Cultured; Vanadates | 1995 |
Differential sensitivity of human prostatic cancer cell lines to the effects of protein kinase and phosphatase inhibitors.
Topics: Alkaloids; Antigens, CD; Antigens, Neoplasm; Cell Adhesion Molecules; Cell Division; Endoglin; Enzyme Inhibitors; Ethers, Cyclic; Genistein; Humans; Hyaluronan Receptors; Intercellular Adhesion Molecule-1; Isoflavones; Male; Okadaic Acid; Phosphoprotein Phosphatases; Phosphorylation; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Receptors, Cell Surface; Staurosporine; Tumor Cells, Cultured; Vanadates; Vascular Cell Adhesion Molecule-1 | 1995 |
Differential tyrosine phosphorylation/activation of oncogenic proline-directed protein kinase F(A)/GSK-3alpha in well and poorly differentiated human prostate carcinoma cells.
Topics: Amino Acid Sequence; Calcium-Calmodulin-Dependent Protein Kinases; Cell Differentiation; Enzyme Activation; Enzyme Inhibitors; Genistein; Glycogen Synthase Kinase 3; Humans; Male; Molecular Sequence Data; Oncogenes; Phosphorylation; Prostatic Neoplasms; Tumor Cells, Cultured; Tyrosine; Vanadates | 1998 |
Vanadate-induced expression of hypoxia-inducible factor 1 alpha and vascular endothelial growth factor through phosphatidylinositol 3-kinase/Akt pathway and reactive oxygen species.
Topics: Antioxidants; Endothelial Growth Factors; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Kinetics; Lymphokines; Male; MAP Kinase Kinase Kinase 1; Phosphatidylinositol 3-Kinases; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Transcription Factors; Tumor Cells, Cultured; Vanadates; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2002 |